POMC, PCSK1, and LEPR Deficiency (Adults and Pediatric Patients Aged 6 Years and Older) The safety of IMCIVREE was evaluated in two 52-week, open-label clinical trials of 27 patients aged 6 years and older with obesity due to POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPRgenes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (Trial 3 and Trial 4) [see Clinical Studies (14.3)]
The link between IGF-1 and cancer is complex
GLP-1RA
Effects are gradual and depend on your diet, activity, and starting blood sugar levels
Ongoing coaching Medication is only one component of effective weight management
however, the incidence of acute gallbladder disease was greater in Wegovy patients than in placebo patients, even after accounting for the degree of weight loss